查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401006

泌尿道感染治療市場，按藥物、適應症、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Urinary Tract Infection Therapeutics Market, By Drug, By Indication, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 277 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年，泌尿道感染治療市場規模為 72 億美元，2023 年至 2030 年CAGR為 2.50%。

尿路感染治療市場-市場動態

對抗生素抗藥性的日益擔憂推動市場需求

隨著引起泌尿道感染的細菌對常用抗生素產生抗藥性，迫切需要開發新的、更有效的療法。這推動了研究和開發工作，以確定新的抗菌藥物，研究疫苗接種等替代治療方式，並鼓勵負責任地使用抗生素以減少抗藥性。日益嚴重的抗生素抗藥性尿路感染問題鼓勵製藥公司、研究人員和醫療保健專業人員探索創造性的方法，以保持尿路感染的可控性，並使患者即使在細菌抗藥性不斷發展的情況下也能接受有效的治療。

尿路感染治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球泌尿道感染治療市場在預測期內（2023-2030）每年將以 2.50% 左右的CAGR成長

由於對抗生素抗藥性的日益擔憂，尿路感染治療產業預計將以顯著的速度成長。

根據藥物細分，青黴素及其組合藥物預計將在 2022 年顯示最大的市場佔有率

根據適應症細分，複雜性泌尿道感染是 2022 年的領先藥物

按地區分類，北美是 2022 年的主要收入來源

尿路感染治療市場區隔分析：

全球尿路感染治療市場根據藥物、適應症、配銷通路和地區進行細分。

市面上依藥物分為五類：青黴素及其組合、喹諾酮類、頭孢菌素、唑類及兩性黴素 B、硝基呋喃類、其他。青黴素及其複方藥物在市場上佔據主導地位。由於青黴素和組合藥物能夠有效治療某些引起泌尿道感染的細菌，因此作為泌尿道感染 (UTI) 治療方法的需求量很大。這些抗生素是治療無併發症泌尿道感染的治療手段的一部分，為患者和醫療保健專業人員提供治療這些常見疾病的可靠替代方案。

市場依適應症分為三類：複雜性泌尿道感染、非複雜性泌尿道感染、其他。複雜性尿路感染領域在市場中佔據主導地位，並可能在預測期內保持其主導地位。由於青黴素和組合藥物能夠有效治療某些引起泌尿道感染的細菌，因此作為泌尿道感染 (UTI) 治療方法的需求量很大。這些抗生素是治療無併發症泌尿道感染的治療手段的一部分，為患者和醫療保健專業人員提供治療這些常見疾病的可靠替代方案。

泌尿道感染治療市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。有幾個變數會影響亞太地區對泌尿道感染 (UTI) 藥物的需求。該地區的高人口密度和城市化導致尿路感染增加，因為更多地暴露於可能的危險因素。此外，醫療保健設施的改善和醫療服務的可近性改善了診斷和治療，並提高了人們對泌尿道感染的認知。此外，生活方式和營養的改變也可能導致泌尿道感染。最後，人口老化使得泌尿道感染的可能性更大。隨著醫療保健意識的增強和對有效藥物的需求的增加，製藥公司和醫療保健專業人員正在將泌尿道感染視為亞太地區的關鍵公共衛生問題。

尿路感染治療市場-競爭格局：

泌尿道感染 (UTI) 藥物的競爭環境中充斥著製藥公司，它們都在爭奪這塊蛋糕。此外，常用抗生素的通用版本通常是可以獲得的。新創公司和小型企業也透過開發新的治療和預防方法為該行業做出貢獻。隨著人們對抗生素抗藥性的擔憂加劇，公司正專注於研究生產新的、更有效的泌尿道感染藥物。市場競爭推動了替代藥物、疫苗接種和非抗生素技術的發展，為患者提供了更多的泌尿道感染治療選擇。

最近的發展：

2023年4月，英國製藥公司葛蘭素史克（GSK.L）透露，其用於治療成年女性和青少年單純性泌尿道感染（uUTI）的口服抗生素藥物實現了後期研究的主要目標。據製造商稱，這種藥物 Gepotidacin 實現了與呋喃妥因相當或更好的關鍵目標，呋喃妥因是目前治療 uUTI 的護理方案。

目錄

第1章：尿路感染治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 泌尿道感染治療市場片段（按藥物）
    • 泌尿道感染治療市場片段（按適應症）
    • 按配銷通路的尿路感染治療市場片段
    • 按國家/地區分類的泌尿道感染治療市場片段
    • 按地區分類的泌尿道感染治療市場片段
  • 競爭洞察

第 3 章：泌尿道感染治療主要市場趨勢

  • 尿路感染治療市場促進因素
    • 市場促進因素的影響分析
  • 尿路感染治療市場限制
    • 市場限制影響分析
  • 尿路感染治療市場機會
  • 尿路感染治療市場未來趨勢

第 4 章：泌尿道感染治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：泌尿道感染治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：泌尿道感染治療市場格局

  • 2022 年泌尿道感染治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：泌尿道感染治療市場 - 按藥物

  • 概述
    • 按藥物分類的細分市場佔有率分析
    • 青黴素及其組合
    • 奎諾酮類
    • 頭孢菌素
    • 唑類和兩性黴素 B
    • 硝基呋喃類
    • 其他

第 8 章：泌尿道感染治療市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 複雜性泌尿道感染
    • 單純性泌尿道感染
    • 其他

第 9 章：泌尿道感染治療市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院
    • 藥局
    • 婦科及泌尿科診所

第 10 章：泌尿道感染治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美尿路感染治療藥物主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲泌尿道感染治療藥物主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按藥品）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區泌尿道感染治療藥物主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區藥物市場規模與預測
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲尿路感染治療藥物主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按藥品）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲泌尿道感染治療藥物主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥品）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 泌尿道感染治療產業

  • 競爭儀表板
  • 公司簡介
    • AstraZeneca
    • GlaxoSmithKline
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Allergan
    • Novartis
    • Bayer AG
    • Johnson & Johnson
    • Ferring Pharmaceuticals
    • Cipla
    • Sun Pharmaceutical Industries
    • Lupin Limited
    • Teva Pharmaceuticals
    • Dr. Reddy's Laboratories
    • Zydus Cadila

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1970

REPORT HIGHLIGHT

Urinary Tract Infection Therapeutics Market size was valued at USD 7,200 Million in 2022, expanding at a CAGR of 2.50 % from 2023 to 2030.

Urinary tract infection (UTI) therapies are a group of medical treatments and pharmacological interventions used to diagnose, prevent, and treat infections of the urinary system. UTIs are caused by bacterial infections in the bladder or urethra, which cause symptoms including pain, frequent urination, and discomfort. UTI treatments include antibiotics such as nitrofurantoin and ciprofloxacin, which target and kill the infection-causing bacteria. Additionally, supportive therapies may include analgesics for discomfort alleviation and infection prevention techniques. UTI treatments are critical in giving comfort, avoiding complications such as kidney infections, and increasing the quality of life for those suffering from these prevalent and sometimes severe diseases.

Urinary Tract Infection Therapeutics Market- Market Dynamics

Growing concern over antibiotic resistance propel market demand

As the bacteria that cause UTIs gain resistance to frequently used antibiotics, there is an urgent need for the development of new and more effective therapies. This has fueled research and development efforts to identify new antimicrobial drugs, investigate alternative treatment modalities such as vaccinations, and encourage responsible antibiotic usage in order to reduce resistance. The growing issue of antibiotic-resistant UTIs encourages pharmaceutical firms, researchers, and healthcare professionals to explore creative ways to keep UTIs manageable and patients receiving effective therapy even as bacterial resistance evolves.

Urinary Tract Infection Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global Urinary Tract Infection Therapeutics market is estimated to grow annually at a CAGR of around 2.50% over the forecast period (2023-2030)

The Urinary Tract Infection Therapeutics industry is projected to grow at a significant rate due to growing concern over antibiotic resistance.

Based on Drug segmentation, Penicillin and Combinations was predicted to show maximum market share in the year 2022

Based on Indication segmentation, Complicated UTI was the leading Drug in 2022

On the basis of region, North America was the leading revenue generator in 2022

Urinary Tract Infection Therapeutics Market- Segmentation Analysis:

The Global Urinary Tract Infection Therapeutics Market is segmented on the basis of Drug, Indication, Distribution Channel, and Region.

The market is divided into five categories based on Drug: Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, Others. The Penicillin and Combinations dominates the market. Because of their efficiency in treating some UTI-causing bacteria, penicillin and combination medicines are in high demand as urinary tract infection (UTI) therapies. These antibiotics are part of the treatment arsenal for uncomplicated UTIs, providing patients and healthcare professionals with dependable alternatives for treating these prevalent illnesses.

The market is divided into three categories based on Indication: Complicated UTI, Uncomplicated UTI, Others. The Complicated UTI sector dominates the market and is likely to maintain its dominance during the forecast period. Because of their efficiency in treating some UTI-causing bacteria, penicillin and combination medicines are in high demand as urinary tract infection (UTI) therapies. These antibiotics are part of the treatment arsenal for uncomplicated UTIs, providing patients and healthcare professionals with dependable alternatives for treating these prevalent illnesses.

Urinary Tract Infection Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables impact the need for urinary tract infection (UTI) medicines in the Asia-Pacific area. The region's high population density and urbanization lead to a rise in UTIs owing to greater exposure to possible risk factors. Additionally, improved healthcare facilities and accessibility to medical services have resulted in improved diagnosis and treatment, as well as increased awareness of UTIs. Furthermore, lifestyle and nutritional changes may lead to UTIs. Finally, the growing older population makes UTIs more likely. Pharmaceutical firms and healthcare professionals are treating UTIs as a key public health problem in the Asia-Pacific region as healthcare awareness grows and demand for effective medicines increases.

Urinary Tract Infection Therapeutics Market- Competitive Landscape:

The competitive environment in urinary tract infection (UTI) medicines is crowded with pharmaceutical firms fighting for a piece of the pie. Furthermore, generic versions of commonly used antibiotics are generally accessible. Startups and smaller businesses also contribute to the industry by developing new treatment and preventative approaches. Companies are focused on research to produce new, more effective UTI medicines as worries about antibiotic resistance rise. The competition in the market pushes the development of alternative medicines, vaccinations, and non-antibiotic techniques, providing patients with a larger choice of UTI management alternatives.

Recent Developments:

In April 2023, GSK (GSK.L), a British pharmaceutical company, revealed that its oral antibiotic medication for treating uncomplicated urinary tract infections (uUTI) in female adults and adolescents fulfilled the primary objectives in late-stage studies. The medicine, gepotidacin, accomplished its key aims of being on par with or better than nitrofurantoin, the current course of care for the therapy of uUTIs, according to the manufacturer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET KEY PLAYERS

  • AstraZeneca
  • GlaxoSmithKline
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Allergan
  • Novartis
  • Bayer AG
  • Johnson & Johnson
  • Ferring Pharmaceuticals
  • Cipla
  • Sun Pharmaceutical Industries
  • Lupin Limited
  • Teva Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Zydus Cadila

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY DRUG

  • Penicillin and Combinations
  • Quinolones
  • Cephalosporin
  • Azoles and Amphotericin B
  • Nitrofurans
  • Others

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY INDICATION

  • Complicated UTI
  • Uncomplicated UTI
  • Others

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

  • Hospital
  • Pharmacies
  • Gynecology and Urology Clinics

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Urinary Tract Infection Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Urinary Tract Infection Therapeutics Market Snippet by Drug
    • 2.1.2. Urinary Tract Infection Therapeutics Market Snippet by Indication
    • 2.1.3. Urinary Tract Infection Therapeutics Market Snippet by Distribution Channel
    • 2.1.4. Urinary Tract Infection Therapeutics Market Snippet by Country
    • 2.1.5. Urinary Tract Infection Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Urinary Tract Infection Therapeutics Key Market Trends

  • 3.1. Urinary Tract Infection Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Urinary Tract Infection Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Urinary Tract Infection Therapeutics Market Opportunities
  • 3.4. Urinary Tract Infection Therapeutics Market Future Trends

4. Urinary Tract Infection Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Urinary Tract Infection Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Urinary Tract Infection Therapeutics Market Landscape

  • 6.1. Urinary Tract Infection Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Urinary Tract Infection Therapeutics Market - By Drug

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug, 2022 & 2030 (%)
    • 7.1.2. Penicillin and Combinations
    • 7.1.3. Quinolones
    • 7.1.4. Cephalosporin
    • 7.1.5. Azoles and Amphotericin B
    • 7.1.6. Nitrofurans
    • 7.1.7. Others

8. Urinary Tract Infection Therapeutics Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 8.1.2. Complicated UTI
    • 8.1.3. Uncomplicated UTI
    • 8.1.4. Others

9. Urinary Tract Infection Therapeutics Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital
    • 9.1.3. Pharmacies
    • 9.1.4. Gynecology and Urology Clinics

10. Urinary Tract Infection Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Urinary Tract Infection Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Urinary Tract Infection Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Urinary Tract Infection Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Urinary Tract Infection Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Urinary Tract Infection Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Urinary Tract Infection Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca
    • 11.2.2. GlaxoSmithKline
    • 11.2.3. Merck & Co., Inc.
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Allergan
    • 11.2.6. Novartis
    • 11.2.7. Bayer AG
    • 11.2.8. Johnson & Johnson
    • 11.2.9. Ferring Pharmaceuticals
    • 11.2.10. Cipla
    • 11.2.11. Sun Pharmaceutical Industries
    • 11.2.12. Lupin Limited
    • 11.2.13. Teva Pharmaceuticals
    • 11.2.14. Dr. Reddy's Laboratories
    • 11.2.15. Zydus Cadila

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Indications
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Urinary Tract Infection Therapeutics Market: Drug Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug
  • TABLE Global Urinary Tract Infection Therapeutics Market, by Drug 2018-2030 (USD Million)
  • TABLE Urinary Tract Infection Therapeutics Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Urinary Tract Infection Therapeutics Market, by Indication 2018-2030 (USD Million)
  • TABLE Urinary Tract Infection Therapeutics Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Urinary Tract Infection Therapeutics Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Urinary Tract Infection Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Urinary Tract Infection Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE North America Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE Europe Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE Latin America Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Urinary Tract Infection Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug segment market share analysis, 2022 & 2030
  • FIGURE Drug segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE Europe Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Urinary Tract Infection Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Urinary Tract Infection Therapeutics Market share analysis by country, 2022
  • FIGURE India Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Urinary Tract Infection Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Urinary Tract Infection Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)